![](/img/cover-not-exists.png)
Radioimmunotherapy for non-Hodgkin's lymphoma: positioning, safety, and efficacy of 90Y-ibritumomab. 10 years of experience and follow-up
Martínez, A., Martínez-Ramirez, M., Martínez-Caballero, D., Beneit, P., Clavel, J., Figueroa, G., Verdú, J.Volume:
36
Journal:
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
DOI:
10.1016/j.remnie.2016.10.002
Date:
January, 2017
File:
PDF, 472 KB
2017